Late-stage cancer patients given LSD micro doses

Checkpoint - A podcast by RNZ - Mondays

Try Bookbeat 60! days for free, click here

Enjoy a whole world of audiobooks and e-books, everything from new releases to the classics

Sponsored

University of Auckland researchers have recruited 40 people for the trial - who will receive either a low dose of the psychedelic hallucinogen or placebos - alongside pyschotherapy, Dr Lisa Reynolds from the School of Psychological Medicine at University of Auckland speaks to Susana Lei'ataua.

Visit the podcast's native language site